Explore 3 Stock Ideas & Industry Insights Download Free Report

Nano X Imaging Ltd

Company price
0.2402 USD -0.01 ( 3.26%)
Last update at 2026-11-06T21:00:00Z
VOLUME
1837357
Market Cap
53.99M

Momentum Score

…

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.21
Low
0.27
High
52 Week Price Range
0.67
Low
4.71
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Nano-X Imaging Ltd develops a compact digital X‑ray system using electronic beam technology to lower cost and enable mobile radiography, aiming to expand access in emerging and underserved markets. Long-term growth drivers include replacement of legacy analog systems and expansion into software and services, which could support scalable recurring revenue and broader adoption.

Key risks are regulatory and reimbursement uncertainty, commercialization and scaling execution, competition from established imaging vendors, and potential need for additional capital.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.25
Dividend Yield
-
Revenue TTM
15.63M
Revenue Per Share
0.23
Gross Profit TTM
-12.07M
Debt / Equity
0.06
ROE
-98.98%
Net Debt
-41.30M
ROCE
-41.78%
Diluted EPS TTM
-1.69

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -76.81M -53.87M -61.12M -108.92M -61.85M
Net income -75.02M -53.52M -60.78M -105.24M -61.80M
Selling general administrative 24.46M 24.10M 26.01M 41.25M 34.71M
Selling and marketing expenses 2.63M 1.65M 2.38M 4.38M 7.03M
Gross profit -12.79M -10.61M -6.59M -6.88M -1.51M
Reconciled depreciation 11.70M 11.73M 11.64M 11.51M 2.29M
Ebit -60.70M -56.75M -59.50M -109.71M -63.85M
Ebitda -49.00M -45.01M -47.69M -37.19M -61.56M
Depreciation and amortization 11.70M 11.73M 11.81M 72.52M 2.29M
Operating income -60.70M -56.75M -62.59M -109.71M -61.56M
Other operating expenses 73.72M 68.03M 72.49M 87.79M 62.86M
Interest expense - - - 60.22M 2.00M
Tax provision -1.79M -0.36M -1.29M -3.68M -0.05M
Interest income 1.42M 2.87M 1.65M - -
Net interest income 1.42M 2.87M 1.18M 0.79M -0.29M
Income tax expense -1.79M -0.36M -0.34M -3.68M -0.05M
Total revenue 13.02M 11.28M 9.90M 8.58M 1.30M
Total operating expenses 47.91M 46.14M 56.00M 72.33M 60.05M
Cost of revenue 25.81M 21.89M 16.50M 15.46M 2.82M
Total other income expense net -16.11M 2.87M 1.47M 0.79M -0.29M
Net income from continuing ops -75.02M -53.52M -103.36M -105.24M -61.80M
Net income applicable to common shares - - - -113.24M -61.80M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 162.16M 210.00M 218.65M 253.93M 363.17M
Intangible assets 59.87M 70.00M 80.61M 91.22M 160.12M
Other current assets 2.10M 2.18M 2.32M 1.45M 1.97M
Total liab 22.43M 20.88M 23.13M 29.25M 71.02M
Total stockholder equity 139.73M 189.12M 195.51M 224.68M 292.15M
Other current liab 9.38M 7.82M 7.33M 12.53M 48.34M
Common stock 0.20M 0.18M 0.17M 0.16M 0.15M
Capital stock 0.20M 0.18M 0.17M 0.16M 0.15M
Retained earnings -448.77M -373.75M -320.23M -251.46M -146.21M
Other liab - - - 8.30M 13.53M
Good will 0.32M 0.00M 0.00M 7.42M 58.30M
Other assets - - 0.00M 34.67M 1.18M
Cash 49.15M 39.30M 56.42M 38.46M 66.64M
Total current liabilities 16.89M 13.97M 15.52M 17.07M 52.75M
Current deferred revenue 0.53M 0.14M 0.54M 0.18M 0.25M
Net debt -41.30M -31.86M -48.03M -33.84M -60.87M
Short term debt 4.09M 3.81M 4.35M 0.74M 1.03M
Short long term debt 3.14M 3.06M 3.49M - 0.14M
Short long term debt total 7.85M 7.45M 8.40M 4.62M 5.77M
Other stockholder equity 588.30M 562.69M 515.89M 477.95M 438.82M
Property plant equipment - - - 12.96M 39.16M
Total current assets 66.79M 78.68M 88.64M 82.46M 94.86M
Long term investments - - 0.00M 25.20M 67.84M
Net tangible assets - - - 118.04M 132.02M
Short term investments 10.46M 33.90M 26.01M 39.16M 22.07M
Net receivables 2.01M 1.80M 1.48M 0.98M 1.05M
Long term debt - - - 3.48M 3.80M
Inventory 3.07M 1.49M 2.36M 2.41M 3.13M
Accounts payable 2.89M 2.21M 3.30M 3.62M 3.13M
Accumulated other comprehensive income 0.00M -0.00M -0.30M -1.97M -0.61M
Non currrent assets other 1.63M 11.79M 2.16M 2.93M 1.18M
Non current assets total 95.37M 131.32M 130.01M 171.47M 268.31M
Capital lease obligations 4.71M 4.38M 4.91M 1.14M 1.83M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 33.80M -20.05M 45.92M 14.61M -116.32M
Change to liabilities - - - 0.39M 0.00M
Total cashflows from investing activities 29.37M -20.05M 35.43M 14.61M -116.32M
Net borrowings - - 0.00M -0.14M -0.14M
Total cash from financing activities 21.37M 39.50M 27.25M 0.80M 7.38M
Change to operating activities - - - 10.97M 10.97M
Net income -75.02M -53.52M -60.78M -105.24M -61.80M
Change in cash 9.85M -17.07M 17.85M -28.24M -147.01M
Begin period cash flow 39.30M 56.38M 38.53M 66.77M 213.78M
End period cash flow 49.15M 39.30M 56.38M 38.53M 66.77M
Total cash from operating activities -40.79M -36.60M -44.78M -43.38M -38.07M
Issuance of capital stock 21.20M 37.83M 27.14M 0.00M 0.00M
Depreciation 11.70M 11.73M 11.81M 11.51M 2.29M
Other cashflows from investing activities -0.20M 0.05M -0.37M - -116.32M
Change to inventory -0.33M -0.28M 0.00M - 0.86M
Change to account receivables 0.11M -0.32M -0.51M 0.07M -0.04M
Other cashflows from financing activities - 1.67M 0.11M 0.80M 7.38M
Change to netincome - - - 46.91M 23.73M
Capital expenditures 4.21M 2.77M 3.30M 7.17M 23.16M
Change in working capital 2.77M -1.13M -7.48M -16.95M 2.75M
Stock based compensation 4.19M 7.26M 6.84M 18.62M 18.81M
Other non cash items 17.54M -0.57M 5.21M 52.40M -0.00M
Free cash flow -45.00M -39.37M -48.08M -50.56M -61.23M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NNOX
Nano X Imaging Ltd
-0.01
3.26%
0.24 - - 3.45 0.76 2.03 -7.41
ABT
Abbott Laboratories
-0.03
0.03%
109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC
-3.04
2.90%
101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation
-9.21
2.75%
325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG
-2.15
4.12%
49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Nano X Imaging Ltd

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence"based solution; AI-Based Body Composition Measurement, an artificial intelligence"based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

94 Shlomo Shmeltzer Road, Petah Tikva, Israel, 4970602

972 3 373 59202

197

Name Title Year Born
Ms. Marina Gofman Feler Chief Legal Officer NA
Mr. Ran Poliakine Founder & Chairman 1969
Mr. Erez I. Meltzer CEO & Director 1957
Ran Daniel Chief Financial Officer 1968
Mr. Tal Shank VP of Corp. Devel. 1978
Ms. Tamar Aharon Cohen Exec. VP & Chief Marketing Officer 1977
Mr. Gilad Yron Chief Bus. Officer 1973
Mr. James M. Dara GM of Source & Services Division and Head of Nanox USA 1970
Ms. Lydia Edwards Pres of Nanox US NA
Dr. Ilung Kim Ph.D. Head of Nanox Korea 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…